Homology modelling of 3-oxoacyl-acyl carrier protein synthase II from Mycobacterium tuberculosis H37Rv and molecular docking for exploration of drugs

Journal of Molecular Modeling

Volumn 15, Issue 5, 2009, Pages 453-460

  Singh, Vijai ^a   Somvanshi, Pallavi ^a  

^a Biotech Park   (India)

Author keywords

Drugs; Homology modelling; KAS II; Molecular docking; Mycobacterium tuberculosis

Indexed keywords

3 OXOACYL ACYL CARRIER PROTEIN SYNTHASE; 3 OXOACYL ACYL CARRIER PROTEIN SYNTHASE II; ACYL COENZYME A; AMINO ACID DERIVATIVE; ANTIINFECTIVE AGENT; CERULENIN; FATTY ACID; ISONIAZID; LEVOFLOXACIN; LOPAC T 2008; LOPAC T 9567; MYCOLIC ACID; REGULATOR PROTEIN; RNA; THIOLACTOMYCIN; THIOPHENONE; THIOTETRAMYCIN; THIOTETROMYCIN; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG RESEARCH; DRUG STRUCTURE; DRUG TARGETING; ENZYME CONFORMATION; FATTY ACID SYNTHESIS; MOLECULAR DOCKING; MOLECULAR MODEL; MOLECULAR PHYLOGENY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; PROTEIN STRUCTURE; RNA TRANSLATION; SEQUENCE HOMOLOGY; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

3-OXOACYL-(ACYL-CARRIER-PROTEIN) SYNTHASE; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; FATTY ACIDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; PROTEIN STRUCTURE, SECONDARY; SEQUENCE ALIGNMENT; STRUCTURAL HOMOLOGY, PROTEIN; THERMODYNAMICS;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 63249119476     PISSN: 16102940     EISSN: 09485023     Source Type: Journal    
DOI: 10.1007/s00894-008-0426-5     Document Type: Article

References (22)

1. Cole ST, Brosch R, Parkhill J et al (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544
2. Smith I (2003) Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 16(3):463-496
3. Somvanshi P, Singh V, Seth PK (2008) In silico prediction of epitopes in virulence proteins of Mycobacterium tuberculosis H37Rv for diagnostic and subunit vaccine design. J Proteomics Bioinform 1:143-153
4. Kikuchi S, Rainwater DL, Kolattukudy PE (1992) Purification and characterization of an unusually large fatty acid synthase from Mycobacterium tuberculosis var. bovis BCG. Arch Biochem Biophys 295:318-326
5. Kanehisa M, Goto S, Kawashima S et al (2002) The KEGG databases at GenomeNet. Nucleic Acids Res 30:42-46
6. Kolattukudy PE, Fernandes ND, Azad AK et al (1997) Biochemistry and molecular genetics of cell-wall lipid biosynthesis in mycobacteria. Mol Microbiol 24:263-270
7. Ducasse-Cabanot S, Cohen-Gonsaud M, Marrakchi H et al (2004) In vitro inhibition of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA by isoniazid. Antimicrob Agents Chemother 48:242-249
8. Somvanshi P, Singh V, Seth PK (2008) In silico analysis of subcellular localization of putative proteins of Mycobacterium tuberculosis H37Rv strain. The Internet Journal of Health 7(1)
9. Chopra S, Singh SK, Prasad S et al (2002) Expression, purification, crystallization and preliminary X-ray analysis of the acyl carrier protein synthase (acpS) from Mycobacterium tuberculosis. Acta Cryst D 58:179-181
10. Altschul SF, Thomas LM, Alejandro AS et al (1997) Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389-3402
11. Sali A, Blundell TL (1993) Comparative protein modeling by satisfaction of spatial restrains. J Mol Biol 234:779-815
12. Delano WL (2002) The PYMOL molecular graphics system. Palo Alto CA
13. Laskowski RA, MacArthur MW, Moss DS et al (1993) PROCHECK: A program to check the stereochemical quality of protein structure. J Appl Crystallogr 26:283-291
14. Morris GM, Goodsell DS, Halliday RS et al (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comp Chem 19:1639-1662
15. Thompson JD, Gibson TJ, Plewniak F et al (1997) The CLUSTALX windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876-4882
16. Tamura K, Dudley J, Nei M et al (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596-1599
17. Jacobs W, Brennan P, Curlin G et al (1996) Comparative sequencing. Science 274:17-18
18. Rousseau C, Turner OC, Rush E et al (2003) Sulfolipid deficiency does not affect the virulence of Mycobacterium tuberculosis H37Rv in mice and guinea pigs. Infect Immun 71(8):4684-4690
19. Jeong KW, Lee JY, Kim Y (2007) Homology modeling and docking study of beta-ketoacyl acyl carrier protein synthase III from Entercoccus faecalis. Bull Korean Chem Soc 28(8):1335-1340
20. Srivastava SK, Dube D, Tewari N et al (2005) Mycobacterium tuberculosis NAD+ dependent DNA ligase is selectively inhibited by glycosylamins compared with human DNA ligase I. Nucleic Acids Res 33(22):7090-7101
21. Brotz-Oesterhelt H, Knezevic I, Bartel S et al (2003) Specific and potent inhibition of NAD+-dependent DNA ligase by pyridochromanones. J Biol Chem 278(41):39435-39442
22. Srivastava SK, Dube D, Kukshal V et al (2007) NAD+ -dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: Novel structure-function relationship and identification of a specific inhibitor. Proteins 69(1):97-111